Share on StockTwits
 

Volcano Corp. (NASDAQ:VOLC) is set to issue its Q413 quarterly earnings data on Monday, February 24th. Analysts expect the company to announce earnings of ($0.24) per share and revenue of $103.03 million for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

Shares of Volcano Corp. (NASDAQ:VOLC) opened at 22.01 on Friday. Volcano Corp. has a 52 week low of $16.37 and a 52 week high of $24.57. The stock’s 50-day moving average is $21.37 and its 200-day moving average is $22.02. The company’s market cap is $1.208 billion.

A number of research firms have recently commented on VOLC. Analysts at Zacks reiterated a “neutral” rating on shares of Volcano Corp. in a research note on Tuesday. They now have a $23.00 price target on the stock. On the ratings front, analysts at Raymond James downgraded shares of Volcano Corp. from an “outperform” rating to a “market perform” rating in a research note on Tuesday, January 21st. They now have a $25.00 price target on the stock. Finally, analysts at Leerink Swann downgraded shares of Volcano Corp. from an “outperform” rating to a “market perform” rating in a research note on Tuesday, January 14th. They now have a $23.00 price target on the stock, down previously from $29.00. Two analysts have rated the stock with a sell rating, twelve have given a hold rating and four have given a buy rating to the company’s stock. Volcano Corp. currently has a consensus rating of “Hold” and an average target price of $23.79.

In other Volcano Corp. news, Insider Jorge Quinoy sold 6,357 shares of the company’s stock on the open market in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $21.96, for a total value of $139,599.72. Following the sale, the insider now directly owns 106,981 shares of the company’s stock, valued at approximately $2,349,303. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Volcano Corporation (NASDAQ:VOLC) designs, develops, manufactures and commercializes a range of precision guided therapy tools, including intravascular ultrasound (IVUS), and fractional flow reserve (FFR), products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.